Vaccine exclusively delivered with the PharmaJet Stratis® Needle-free Injection System December 13, 2022 11:00 AM Eastern Standard Time GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet®, a company that engineers precision delivery systems that overcome ...
November 08, 2022 08:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held clinical-stage biotechnology company pioneering the development of LAMP-mediated nucleic acid-based immunotherapy, today announced ...
October 10, 2022 09:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy announced today ...
ITI to participate in Endpoints webinar, “Overcoming Manufacturing Challenges for Advanced Medicines” 11/1, 12-1pm EST
Brian Stamper, VP Cell Therapy Operations will participate in the Endpoints webinar titled “Overcoming Manufacturing Challenges for Advanced Medicines” on November 1st from 12-1pm EST. Click here to register: https://webinars.endpts.com/overcoming-manufacturing-challenges-for-advanced-medicines/ ...
ITI will be attending The 41st Annual Health Care Conference that will take place on January 9-11, 2023 at the Westin St. Francis in San Francisco, CA. This premier conference ...
Immunomic Therapeutics Announces the Appointment of Frances Harrison as Senior Vice President, Regulatory Affairs September 06, 2022 09:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), ...
ITI Announces First Patient Dosed in Phase I Clinical Trial of ITI-3000 pDNA Vaccine for the Treatment of Merkel Cell Carcinoma
Immunomic Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ITI-3000 pDNA Vaccine for the Treatment of Merkel Cell Carcinoma -Top line data expected in second half of ...
https://www.stachestrong.org/ Friday, October 21st Annual Fundraiser in NYC StacheStrong is a 501(c)3 non-profit devoted to raising funds and awareness for brain cancer research. Defeating brain cancer and improving the quality ...
Vaccines Summit-2022 October 11-13, 2022 in Washington DC Organized around the theme “next-generation vaccines treatment and diagnostics that save lives”, Vaccines Summit-2022 is comprised of various sessions designed to offer comprehensive symposiums ...
https://biobuzz.io/brian-stamper-appointed-vice-president-cell-therapy-operations-at-immunomic-therapeutics/
June 07, 2022 10:24 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP (Lysosome Associated Membrane Protein) -mediated nucleic ...
Immunomic Therapeutics highlighted in Washington Business Journal as a life sciences leader in Maryland’s Montgomery County: The Immunology Capital Next to the Nation’s Capital. Click here to read more: http://ow.ly/NQrc50IVzkT